Abdisa Tufa Bedada

Cisplatin nephrotoxicity in cervical and ovarian cancer: Incidence, risk factors, and prevention in a resource-limited setting

Background Cisplatin induced nephrotoxicity affects approximately 30% of treated patients and remains the primary dose limiting toxicity of this essential chemotherapeutic agent. In resource-limited settings, inconsistent implementation of prevention protocols may increase nephro...